CK18F levels in histologically confirmed GVHD of gut, liver, and skin
UPN . | Day of onset after TPL . | Histo-grading . | Before SCT CK18F, U/L . | CK18F at symptom maximum, U/L . |
---|---|---|---|---|
Gut | ||||
301 | 15 | III-IV | 275 | 1276 |
284 | 18 | II-III | 81 | 685 |
304 | 21 | II | 320 | 718 |
210 | 31 | IV | 99 | 568 |
271* | 38* | I* | 124 | 435 |
363* | 91 | IV* | 115 | 347 |
291 | 98 | II-III | 153 | 901 |
189 | 107 | III | 31 | 434 |
211* | 131* | III* | 132 | 560 |
291 | 144 | III-IV | 153 | 1200 |
250* | 145* | IV* | 142 | 561 |
178 | 163 | I-II | ND | 478 |
281 | 210 | I | 123 | 414 |
Liver | ||||
200 | 72 | 18,1† | 159 | 1920 |
288 | 163 | 2,5† | 190 | 6880 |
221 | 250 | 1,4† | 195 | 480 |
Skin | ||||
279 | 44 | II | 196 | 165 |
181 | 61 | IV | 129 | 230 |
277 | 77 | I | 296 | 185 |
UPN . | Day of onset after TPL . | Histo-grading . | Before SCT CK18F, U/L . | CK18F at symptom maximum, U/L . |
---|---|---|---|---|
Gut | ||||
301 | 15 | III-IV | 275 | 1276 |
284 | 18 | II-III | 81 | 685 |
304 | 21 | II | 320 | 718 |
210 | 31 | IV | 99 | 568 |
271* | 38* | I* | 124 | 435 |
363* | 91 | IV* | 115 | 347 |
291 | 98 | II-III | 153 | 901 |
189 | 107 | III | 31 | 434 |
211* | 131* | III* | 132 | 560 |
291 | 144 | III-IV | 153 | 1200 |
250* | 145* | IV* | 142 | 561 |
178 | 163 | I-II | ND | 478 |
281 | 210 | I | 123 | 414 |
Liver | ||||
200 | 72 | 18,1† | 159 | 1920 |
288 | 163 | 2,5† | 190 | 6880 |
221 | 250 | 1,4† | 195 | 480 |
Skin | ||||
279 | 44 | II | 196 | 165 |
181 | 61 | IV | 129 | 230 |
277 | 77 | I | 296 | 185 |